| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |